Goldner, Gregor <br/><br/>
Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial.  [electronic resource] 

 -  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]  Feb 2009 
 - 94-100 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1439-099X 
<br/><br/><label>Standard No.: </label>10.1007/s00066-009-1970-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Austria--epidemiology<br/>Dose Fractionation, Radiation<br/>Germany--epidemiology<br/>Humans<br/>Male<br/>Middle Aged<br/>Prevalence<br/>Prospective Studies<br/>Prostatic Neoplasms--mortality<br/>Radiotherapy, Conformal--mortality<br/>Risk Assessment--methods<br/>Risk Factors<br/>Survival Analysis<br/>Survival Rate<br/>Treatment Outcome